Novel Production of Cannabinoids with Sher Ali Butt CB Therapeutics

Published: Feb. 27, 2017, 8:48 p.m.

Sher Ali Butt, CEO, CB Therapeutics was presenting at a recent University of California San Diego IGNITE Innovator & Entrepreneur conference.\xa0 He was there to highlight their novel way of producing cannabinoids in yeast bypassing the need for land, water and other elements involved with growing cannabis plants to extract the cannabinoids.\xa0 Using biosynthesis technologies they are able to produce CBD isolate with a high level of purity in under 6 days costing on average $5/gram of pure compounds.\xa0 Now it is up to the medical profession to find new ways to use CBD instead of opiates and other pain medications.

@CBTherapeutics\xa0

CB Therapeutics